Assuming approach is required, the following results were found.

  • What's New in Stem Cells? Expert Discusses Hematopoietic Status and Newer Mesenchymal Approaches

    been described as a promising and powerful therapeutic strategy for severe multiple sclerosis (MS), a highly experimental approach, or a dubious sham treatment preying on unwary patients. So, which is correct? This depends upon which type of SCT one is...

    https://mschristian.org/index.php/what-s-new-in-stem-cells-expert-discusses-hematopoietic-status-and-newer-mesenchymal-approaches
  • Study: Transcarotid Stenting Has a Leg Up Over Femoral Approach

    stroke risk in carotid artery stenting was associated with better outcomes compared to the conventional transfemoral approach to the carotids, a study showed. By avoiding the aortic arch with direct common carotid access and utilizing flow reversal...

    https://mschristian.org/index.php/articles/2-uncategorised/9613-study-transcarotid-stenting-has-a-leg-up-over-femoral-approach
  • June Halper Describes the Team-Based Approach Underlying the Consortium of MS Centers

    executive officer, Consortium of Multiple Sclerosis Centers. Click to listen to June Halper as she describes a Team-based approach to care........................................................................................................ This...

    https://mschristian.org/index.php/articles/2-uncategorised/8973-june-halper-describes-the-team-based-approach-underlying-the-consortium-of-ms-centers
  • Anokion Presents New Data Describing Transformative Therapeutic Approach for Treatment of Multiple Sclerosis at ECTRIMS Congress - streetinsider.com

    to access https://www.streetinsider.com/Business Wire/Anokion Presents New Data Describing Transformative Therapeutic Approach for Treatment of Multiple Sclerosis at ECTRIMS Congress/15912284.html from 204.152.211.44 on 2019-09-15 15:50:00 UTC. Trace:...

    https://mschristian.org/index.php/articles/2-uncategorised/8606-anokion-presents-new-data-describing-transformative-therapeutic-approach-for-treatment-of-multiple-sclerosis-at-ectrims-congress-streetinsider-com
  • Research on immune activity in MS

    through further research, these basic laboratory studies could eventually be translated to promising new therapeutic approaches to stimulating myelin repair to restore function in people with MS. Read more Treatment with ATX-MS-1467 (Apitope) – an...

    https://mschristian.org/index.php/blog/research-on-immune-activity-in-ms
  • To stay younger for longer, make this change to your diet - Haaretz

    the currently accepted recommendations in this realm suffer from an underlying, fundamental problem. Hunger as natural The approach supporting partial fasting on a daily basis stems from a basic truth that has been forgotten over the years: Hunger is...

    https://mschristian.org/index.php/blog/to-stay-younger-for-longer-make-this-change-to-your-diet-haaretz
  • Researchers develop a potential treatment approach for Pelizaeus-Merzbacher disease

    This treatment reduced PMD's hallmark symptoms and extended lifespan, establishing the clinical potential of this approach. By demonstrating effective delivery of the ASOs to myelin-producing cells in the nervous system, researchers raised the prospect...

    https://mschristian.org/index.php/researchers-develop-a-potential-treatment-approach-for-pelizaeus-merzbacher-disease
  • Link between gut flora and multiple sclerosis discovered

    can soon also be translated into therapy; she plans to test the immunoactive components of GDP-L-fucose synthase using an approach that the researchers have been pursuing for several years already. Date: Source: University of Zurich Summary: In...

    https://mschristian.org/index.php/blog/link-between-gut-flora-and-multiple-sclerosis-discovered
  • Study: Transcarotid Stenting Has a Leg Up Over Femoral Approach

    stroke risk in carotid artery stenting was associated with better outcomes compared to the conventional transfemoral approach to the carotids, a study showed. By avoiding the aortic arch with direct common carotid access and utilizing flow reversal...

    https://mschristian.org/index.php/blog/study-transcarotid-stenting-has-a-leg-up-over-femoral-approach
  • June Halper Describes the Team-Based Approach Underlying the Consortium of MS Centers

    executive officer, Consortium of Multiple Sclerosis Centers. Click to listen to June Halper as she describes a Team-based approach to care........................................................................................................ This...

    https://mschristian.org/index.php/blog/june-halper-describes-the-team-based-approach-underlying-the-consortium-of-ms-centers
  • Anokion Presents New Data Describing Transformative Therapeutic Approach for Treatment of Multiple Sclerosis at ECTRIMS Congress - streetinsider.com

    to access https://www.streetinsider.com/Business Wire/Anokion Presents New Data Describing Transformative Therapeutic Approach for Treatment of Multiple Sclerosis at ECTRIMS Congress/15912284.html from 204.152.211.44 on 2019-09-15 15:50:00 UTC. Trace:...

    https://mschristian.org/index.php/blog/anokion-presents-new-data-describing-transformative-therapeutic-approach-for-treatment-of-multiple-sclerosis-at-ectrims-congress-streetinsider-com
  • New compound offers superior therapeutic approach to treat MS

    increasing the risk of cancer, heart disease and stroke. An interdisciplinary team of scientists have piggy-backed on this approach with a new concept that side steps the negative side effects while alleviating symptoms. In a paper published on January...

    https://mschristian.org/index.php/blog/new-compound-offers-superior-therapeutic-approach-to-treat-ms
  • Link between gut flora and multiple sclerosis discovered

    can soon also be translated into therapy; she plans to test the immunoactive components of GDP-L-fucose synthase using an approach that the researchers have been pursuing for several years already. Re-educating the immune system "Our clinical...

    https://mschristian.org/index.php/articles/2-uncategorised/8746-link-between-gut-flora-and-multiple-sclerosis-discovered
  • Studies Report on Efforts to Optimize Rituximab in MS, NMOSD - The Center for Biosimilars

    optica spectrum disorder (NMOSD) using rituximab.2 In the study, 15 patients with NMOSD were treated using a standard approach, under which rituximab is readministered only once memory B cells reached 0.05% of peripheral blood mononuclear cells, and 29...

    https://mschristian.org/index.php/articles/2-uncategorised/8691-studies-report-on-efforts-to-optimize-rituximab-in-ms-nmosd-the-center-for-biosimilars
  • A new way to estimate neurologic disease prevalence in the United States: Illustrated with MS

    current health care era. Methods We carried out a strengths, weaknesses, opportunities, and threats (SWOT) analysis for 3 approaches to estimate MS prevalence: population-based MS registries, national probability health surveys, and analysis of...

    https://mschristian.org/index.php/blog/a-new-way-to-estimate-neurologic-disease-prevalence-in-the-united-states-illustrated-with-ms
  • "Treating MS: A Simplified Strategy Boosts Patient and Provider Satisfaction"

    Both the busy clinician and the overwhelmed patient benefit from a pointed approach to disease management. By: Aaron Boster, MD Published: December 02, 2019 As the field of neuroimmunology evolves at an unprecedented rate, keeping up with the latest...

    https://mschristian.org/index.php/blog/treating-ms-a-simplified-strategy-boosts-patient-and-provider-satisfaction
  • Sanofi and Happify Health solidify collaboration around prescription DTx designed to address mental health in people with MS

    September 2019 – Companies plan to seek FDA clearance for digital therapeutics approach – The list of physical symptoms of multiple sclerosis (MS) is long and varied, including fatigue, numb limbs and tremors. But many people living with MS also...

    https://mschristian.org/index.php/blog/sanofi-and-happify-health-solidify-collaboration-around-prescription-dtx-designed-to-address-mental-health-in-people-with-ms
  • Studies Report on Efforts to Optimize Rituximab in MS, NMOSD - The Center for Biosimilars

    optica spectrum disorder (NMOSD) using rituximab.2 In the study, 15 patients with NMOSD were treated using a standard approach, under which rituximab is readministered only once memory B cells reached 0.05% of peripheral blood mononuclear cells, and 29...

    https://mschristian.org/index.php/blog/studies-report-on-efforts-to-optimize-rituximab-in-ms-nmosd-the-center-for-biosimilars
  • Genentech to Present Pivotal Data for Satralizumab in Neuromyelitis Optica Spectrum Disorder and Six-year Ocrevus (Ocrelizumab) Data in Multiple Sclerosis at ECTRIMS

    Data being presented at ECTRIMS include positive Phase III results for satralizumab as a monotherapy, taking a novel approach to treating neuromyelitisoptica spectrum disorder, and new insights using biomarkers to identify disease progression in...

    https://mschristian.org/index.php/blog/genentech-to-present-pivotal-data-for-satralizumab-in-neuromyelitis-optica-spectrum-disorder-and-six-year-ocrevus-ocrelizumab-data-in-multiple-sclerosis-at-ectrims
  • Central Michigan Hospital plots leadership path in MS research (Blood testing for MS, NeuroFilaments and more)

    tested that will help doctors pinpoint stage of disease and best drug to slow debilitating effects Multi-disciplinary team approach cuts testing and diagnosis process to one day Rany Aburashed, D.O. Neurologist Rany Aburashed, D.O., is leading Memorial...

    https://mschristian.org/index.php/blog/central-michigan-hospital-plots-leadership-path-in-ms-research-blood-testing-for-ms-neurofilaments-and-more

Results 1 - 20 of 120